KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 8 analysts with an average price target of $34.26. This is a potential upside of $14.13 (70.19%) from yesterday's end of day stock price of $20.13.

Keros Therapeutics 's activity chart (see below) currently has 58 price targets and 66 ratings on display. The stock rating distribution of KROS is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.48% with an average time for these price targets to be met of 54.92 days.

Highest price target for KROS is $27, Lowest price target is $15, average price target is $22.86.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 12-Nov-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 15 are a BUY (71.43%), 6 are a HOLD (28.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$27

$9.5 (54.29%)

$23

1 months 6 days ago
(12-Nov-2025)

0/8 (0%)

$9.53 (54.55%)

Hold

$16

$-1.5 (-8.57%)

$15

1 months 12 days ago
(06-Nov-2025)

3/4 (75%)

$-0.17 (-1.05%)

70

Buy

$26

$8.5 (48.57%)

$26

1 months 28 days ago
(20-Oct-2025)

1/4 (25%)

$10.81 (71.17%)

74

Buy

$26

$8.5 (48.57%)

$41

7 months 6 days ago
(12-May-2025)

1/6 (16.67%)

$12.26 (89.23%)

215

Buy

$25

$7.5 (42.86%)

$40

7 months 10 days ago
(08-May-2025)

1/14 (7.14%)

$10.98 (78.32%)

113

Show more analysts

Please expand the browser size to see the chart

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 54.92 days on average for the stock forecasts to be realized with a an average price target met ratio 39.48

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Danielle Brill works at TRUIST and has 7 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Tom Smith with highest potential upside - $62.5

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Joseph Catanzaro with lowest potential downside - -$2.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?